Literature DB >> 15050625

Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffold.

Manish Tandon1, David L Coffen, Paul Gallant, Dennis Keith, Mark A Ashwell.   

Abstract

The preparation and structure-activity relationships (SARs) of potent and selective small molecule inhibitors of bacterial methionyl-tRNA synthetase (MetRS) derived from an oxazolone-dipeptide scaffold are described. Examples combine Staphylococcus aureus MetRS (SaMetRS) potency with selectivity over human MetRS. As a result of the SAR expansion compound 14a was identified, as a potent SaMetRS inhibitor (IC(50)=18 nM) having moderate inhibition of MetRS derived from Enterococci faecalis (IC(50)=3.51 microM).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050625     DOI: 10.1016/j.bmcl.2004.01.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  IA, database of known ligands of aminoacyl-tRNA synthetases.

Authors:  Mieczyslaw Torchala; Marcin Hoffmann
Journal:  J Comput Aided Mol Des       Date:  2007-09-20       Impact factor: 3.686

2.  Inhibition of methionyl-tRNA synthetase by REP8839 and effects of resistance mutations on enzyme activity.

Authors:  Louis S Green; James M Bullard; Wendy Ribble; Frank Dean; David F Ayers; Urs A Ochsner; Nebojsa Janjic; Thale C Jarvis
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

3.  A homology model for Clostridium difficile methionyl tRNA synthetase: active site analysis and docking interactions.

Authors:  Ehab Al-Moubarak; Claire Simons
Journal:  J Mol Model       Date:  2010-11-02       Impact factor: 1.810

4.  Tuning photoinduced intramolecular electron transfer by electron accepting and donating substituents in oxazolones.

Authors:  Gülsiye Oztürk; Hasan Karabıyık; Muhittin Aygün; Serap Alp; Serdar Ozçelik
Journal:  J Fluoresc       Date:  2013-03-15       Impact factor: 2.217

5.  Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.

Authors:  Laura Pedró-Rosa; Frederick S Buckner; Ranae M Ranade; Christina Eberhart; Franck Madoux; J Robert Gillespie; Cho Yeow Koh; Steven Brown; Jacqueline Lohse; Christophe L M Verlinde; Erkang Fan; Thomas Bannister; Louis Scampavia; Wim G J Hol; Timothy Spicer; Peter Hodder
Journal:  J Biomol Screen       Date:  2014-08-27

6.  Novel hybrid virtual screening protocol based on molecular docking and structure-based pharmacophore for discovery of methionyl-tRNA synthetase inhibitors as antibacterial agents.

Authors:  Chi Liu; Gu He; Qinglin Jiang; Bo Han; Cheng Peng
Journal:  Int J Mol Sci       Date:  2013-07-09       Impact factor: 5.923

7.  Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides.

Authors:  Ahmad J Almalki; Tarek S Ibrahim; Ehab S Taher; Mamdouh F A Mohamed; Mahmoud Youns; Wael A H Hegazy; Amany M M Al-Mahmoudy
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

8.  4-[(3-Meth-oxy-anilino)methyl-idene]-2-phenyl-1,3-oxazol-5(4H)-one.

Authors:  Wan-Yun Huang; Ye Zhang; Kun Hu; Qing-Mei Lin; Xian-Xian Liu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-10

Review 9.  Evolutionary Limitation and Opportunities for Developing tRNA Synthetase Inhibitors with 5-Binding-Mode Classification.

Authors:  Pengfei Fang; Min Guo
Journal:  Life (Basel)       Date:  2015-12-08

10.  Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis.

Authors:  Sudha Ravishankar; Anisha Ambady; Rayapadi G Swetha; Anand Anbarasu; Sudha Ramaiah; Vasan K Sambandamurthy
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.